lobbying_activities: 2152755

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2152755	6a17de15-4dcc-4677-a9b9-a76a20b343c5	Q2	BUCHANAN INGERSOLL & ROONEY PC	55291	LIPOCINE	2018	second_quarter	PHA	Federal government relations service, strategy development and implementation relating to companys status of FDA action on NDA for oral testosterone.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2018-07-19T06:02:14.670000-04:00